首页> 外文期刊>Macromolecular Research >Acidic pH-stimulated tiotropium release from porous poly(lactic-co-glycolic acid) microparticles containing 3-diethylaminopropyl-conjugated hyaluronate
【24h】

Acidic pH-stimulated tiotropium release from porous poly(lactic-co-glycolic acid) microparticles containing 3-diethylaminopropyl-conjugated hyaluronate

机译:酸性pH刺激的噻托溴铵从含有3-二乙氨基丙基共轭透明质酸盐的多孔聚乳酸-乙醇酸共聚物微粒中释放

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, we developed porous poly(lactide-co-glycolide) (PLGA) microparticles (PM) exhibiting pH-activated drug release properties. The PMs were prepared via the water-in-oil-in-water (W-1/O/W-2) multi-emulsion method using PLGA, 3-diethylaminopropyl amine (DEAP)-conjugated hyaluronate (HA) (HA-DEAP), and an anti-cholinergic model drug (tiotropium). Here, HA-DEAP was incorporated into the PMs; it acted as a drug release activator, accelerating drug release. In vitro drug release studies revealed that the tiotropium was released from the PMs as their pores were destabilized by eletrostatic interactions between the carboxyl groups (negatively charged) of the HA molecules and the tertiary amine groups (positively charged) of the DEAP moieties under acidic environments. This PLGA microparticle system, which contains a HA-DEAP, could provide unique advantages in treating chronic obstructive pulmonary disease (COPD) with chronic respiratory acidosis.
机译:在这项研究中,我们开发了具有pH活化药物释放特性的多孔聚(丙交酯-共-乙交酯)(PLGA)微粒(PM)。通过使用PLGA,3-二乙氨基丙胺(DEAP)共轭透明质酸酯(HA)(HA-DEAP)的水包油包水(W-1 / O / W-2)多乳液方法制备PM )和抗胆碱能模型药物(噻托溴铵)。在这里,HA-DEAP被合并到PM中。它充当药物释放活化剂,加速药物释放。体外药物释放研究表明,在酸性环境下,由于HA分子的羧基(带负电荷)和DEAP部分的叔胺基(带正电荷)之间的静电相互作用,噻托溴铵从PM中释放出来,从而释放了噻托溴铵。包含HA-DEAP的PLGA微粒系统可为治疗慢性呼吸性酸中毒的慢性阻塞性肺疾病(COPD)提供独特的优势。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号